OncoVista Innovative Therapies, Inc. (OTCPK:OVIT) continues to work with its financial advisor, Great Plains Capital Partners, LLC, in assessing merger and acquisition opportunities and other strategic alternatives that would add greater value to the portfolio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.36K | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- OVIT Stock
- News OncoVista Innovative Therapies, Inc.
- OncoVista Mulls Strategic Alternatives